About Ustekinumab Ustekinumab is a monoclonal antibody medication used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,targeting both…
About Infliximab Infliximab, a chimeric monoclonal antibody, is a medication used to treat a number of autoimmune diseases.…
About Belumosudil Belumosudil is a medication used for the treatment of chronic graft versus host disease…
About Resmetirom Resmetirom is a medication used for the treatment of noncirrhotic nonalcoholic steatohepatitis. It is a thyroid hormone receptor beta (NR1A2) agonist.…
About Elafibranor Elafibranor is a medication used for the treatment of primary biliary cholangitis. Elafibranor is a dual PPARα/δ agonist.…
About Pacritinib Pacritinib is a medication used to treat adults with intermediate- or high-risk myelofibrosis (MF),…
About Ritlecitinib Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. Ritlecitinib…
About Momelotinib ONE PILL, ONCE DAILY Momelotinib is an anticancer medication used for the treatment of myelofibrosis. It is a Janus…
About Momelotinib ONE PILL, ONCE DAILY Momelotinib is an anticancer medication used for the treatment of myelofibrosis. It is a Janus…
About Filgotinib Filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults…
About Abrocitinib Abrocitinib is a medication used for the treatment of atopic dermatitis (eczema). It is a Janus kinase inhibitor . In…
About Anamorelin Anamorelin (developmental code names ONO-7643, RC-1291, ST-1291), also known as anamorelin hydrochloride (USAN, JAN), is a non-peptide, orally-active, centrally-penetrant, selective agonist of the ghrelin/growth hormone secretagogue…
About Febuxostat Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients…
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…